C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) serum markers have shown to be higher in women with malignant ovarian tumors while there is uncertainty if serum levels are associated with unique GI microbes [27,28,29,30]. This evidence concerns the gene IL6 and ovarian cancer.